Dogecoin Cash, Inc. (OTC: DOGP)

Dogecoin Cash, Inc. operates a technology-enabled telemedicine platform, PrestoDoctor, which connects patients with licensed physicians for medical cannabis evaluations through secure video consultations. The company primarily serves jurisdictions where such services are permitted under applicable state laws. Dogecoin Cash, Inc. was originally incorporated as Ultra Sun Corporation and later renamed Cannabis Sativa, Inc. before adopting its current name. The company's operations are conducted through its majority-owned subsidiary, PrestoCorp, Inc., which does business as PrestoDoctor.

The company generates substantially all of its revenue from telemedicine consultation services facilitated through the PrestoDoctor platform. Patients schedule consultations through the platform and are connected with licensed physicians who conduct telemedicine consultations remotely using secure online technology. The company operates using an asset-light platform model, which means it facilitates telemedicine services through digital infrastructure rather than owning physical clinic locations or healthcare facilities.

• PrestoDoctor: This segment operates the telemedicine platform that facilitates medical cannabis evaluations conducted by licensed physicians. The platform connects patients with physicians through secure proprietary online technology, enabling telemedicine consultations to occur remotely in jurisdictions where permitted by applicable state laws. The primary product offered is the telemedicine consultation service, which is marketed to patients seeking medical cannabis evaluations.

The company's strategy focuses on expanding its telemedicine platform while maintaining a capital-efficient operating structure. It also maintains intellectual property assets and evaluates technology initiatives through subsidiaries including Dogecoin Treasury Inc., Dogespac LLC, and Meme Coins Inc. The company holds cannabis-related intellectual property through Kubby Patent and Licenses, LLC, which includes the Ecuadorian Sativa cannabis strain plant patent and a patent relating to a method of treating hypertension using a cannabinoid-containing lozenge delivery system.

Dogecoin Cash, Inc. competes with other telemedicine platforms and healthcare technology providers offering remote consultation services. Many competitors may have greater financial resources, larger physician networks, and more extensive technology infrastructure. The company's competitive advantage lies in its asset-light platform model, which allows it to operate efficiently and scale its services without the need for significant capital investment in physical infrastructure.

The general customer base for Dogecoin Cash, Inc. consists of patients seeking medical cannabis evaluations. These patients are typically located in jurisdictions where telemedicine services for medical cannabis evaluations are permitted under applicable state laws. The company's services are also utilized by licensed physicians who conduct consultations through the PrestoDoctor platform. The physicians are independent medical professionals responsible for complying with applicable professional licensing and regulatory requirements.